![Nirmala Bhoo Pathy: Nominated for the Tatler Asia’s Front and Female Awards Malaysia 2024](https://oncodaily.com/pub/uploads/2024/02/21112517-ffnominees-hero-option1_cover_1600x1067.png)
Nirmala Bhoo Pathy: Nominated for the Tatler Asia’s Front and Female Awards Malaysia 2024
shared a post by Rachel Duffell, Regional Content Director, Front & Female at Tatler Asia Group
“Nominated for the Tatler Asia’s Front & Female Awards Malaysia 2024.
Front row seat to greatness, but the real magic? Sharing it with incredible women! I’m truly humbled to be surrounded by such inspiring forces. Their dedication to doing good makes me realize we’re all part of something bigger, and that’s truly motivating.”
Quoting Rachel Duffell’s post:
“We’ve just announced the nominees for this year’s Tatler Asia Front & Female Awards Malaysia 2024!
These are the nominated individuals who are inspiring progress for women and girls and affecting change for women, either directly or indirectly through their work and lives.
Congratulations to Abir Abdul Rahim Tehmina Kaoosji Nirmala Bhoo Pathy MD PhD Reita Rahim Penny Choo Rozana Isa Violette Tan Nik Suzila Soo-Hwang Teo Maheswari Jaganathan Goh Suet Lan Melissa M. Akhir (She/Her) Min Lim Juliana Adam Sharuna Verghis Amanda Nell Eu Rejina Rahim Izza Izelan Nuraizah Shamsul Baharin.
Read more about our nominees.”
Source:
Nirmala Bhoo-Pathy is a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician at Universiti Malaya Medical Centre, Malaysia. She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014.
Dr Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy. Dr Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In ONcology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN).
She currently serves in two Lancet Commissions: the Lancet Commission on Women and Cancer and the Lancet Commission on Cancer and Health Systems. As the founder and scientific lead of a solution-oriented research group ‘Well with Cancer in Malaysia (WeCan@MY) https://spm.um.edu.my/wecan@my/ in the Department of Social and Preventive Medicine, Nirmala Bhoo-Pathy currently oversees a wide range of studies on cancer care, cancer control and cancer policy, locally and globally.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023